Protagonist Therapeutics Inc
XBER:PGF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Protagonist Therapeutics Inc
XBER:PGF
|
US |
|
Perma-Pipe International Holdings Inc
NASDAQ:PPIH
|
US |
|
J
|
Juventus FC SpA
PSE:JUVE
|
IT |
|
Larimar Therapeutics Inc
NASDAQ:LRMR
|
US |
|
Lifecare AS
F:LFC
|
NO |
|
Place Holdings Ltd
SGX:E27
|
SG |
|
J
|
JD.Com Inc
NASDAQ:JD
|
CN |
|
W
|
Walt Disney Co
F:WDP
|
US |
|
Investis Holding SA
SIX:IREN
|
CH |
|
Liontrust Asset Management PLC
LSE:LIO
|
UK |
|
I
|
Itafos
OTC:MBCF
|
KY |
|
Scansource Inc
NASDAQ:SCSC
|
US |
|
Diamondback Energy Inc
NASDAQ:FANG
|
US |
|
Vivoryon Therapeutics NV
AEX:VVY
|
DE |
|
PT Dayamitra Telekomunikasi Tbk
IDX:MTEL
|
ID |
|
A
|
American Airlines Group Inc
F:A1G
|
US |
Intrinsic Value
The intrinsic value for
Protagonist Therapeutics Inc (PGF) under the Base Case is hidden
EUR.
Compared with the current market price of 75 EUR, the stock appears hidden
.
PGF looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PGF usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Protagonist Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Protagonist Therapeutics Inc
Earnings Waterfall
Protagonist Therapeutics Inc
The intrinsic value for
Protagonist Therapeutics Inc (PGF) under the Base Case is hidden EUR.
Compared with the current market price of 75 EUR, the stock appears hidden.